News

A new study from MUSC Hollings Cancer Center researchers shows, for the first time, that a receptor called PPAR δ, or peroxisome proliferator-activated receptor delta, is an important player in a ...
He and his colleagues are actively working on different means to target the METRNL-E2F-PPAR delta pathway or to combine targeted treatment with other immunotherapies.
He and his colleagues are actively working on different means to target the METRNL-E2F-PPAR delta pathway or to combine targeted treatment with other immunotherapies. “We think that one of the reasons ...
He and his colleagues are actively working on different means to target the METRNL-E2F-PPAR delta pathway or to combine targeted treatment with other immunotherapies.
GlobeNewswire Wed, Sep 20, 2017, 12:26 PM GENFIT: Risk of confusion between PPAR alpha/delta Phase 3 drug candidate elafibranor and PPAR a/d/gamma Phase 2 compound lanifibranor ...
In this study, Ghosh and colleagues showed that the metabolism of endocannabinoids by the COX-2 pathway activates PPAR-delta, which suppresses the expression of TF. COX-2 in endothelial cells ...
He and his colleagues are actively working on different means to target the METRNL-E2F-PPAR delta pathway or to combine targeted treatment with other immunotherapies.